Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus
Amrita K Cheema,1 Prabhjit Kaur,1 Amina Fadel,2 Noura Younes,3 Mahmoud Zirie,4 Nasser M Rizk2,5 1Department of Oncology, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC, USA; 2Biomedical Sciences Department, College of Health Sciences and Biomedical Resea...
Saved in:
Main Authors: | Cheema AK, Kaur P, Fadel A, Younes N, Zirie M, Rizk NM |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/113f03c14d3041c29cee9687f2d39e47 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
by: Tafere GG, et al.
Published: (2020) -
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
by: Badawi A
Published: (2010) -
Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
by: Lingxiao Wang, et al.
Published: (2021) -
Novel biomarkers for prediabetes, diabetes, and associated complications
by: Dorcely B, et al.
Published: (2017) -
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
by: Huber CA, et al.
Published: (2014)